Stay updated on Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page
- Check7 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5 to reflect a new page revision.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, signaling a minor page update. This change does not modify the study details or content.SummaryDifference0.0%

- Check50 days agoChange DetectedClinicalTrials.gov’s page release has been updated from Revision v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check72 days agoChange DetectedReplaced Padua, Italy, 35128 with Padova, Italy, 35128 in the location entry to reflect the correct city name.SummaryDifference0.0%

- Check86 days agoChange DetectedNaples, Italy (80131) was added to the list of study locations and Napoli was replaced with Naples. The page also shows a new Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.